Genomic Health, Inc. (GHDX) Misses Q1 EPS by 6c

Genomic Health, Inc. (NASDAQ: GHDX) reported Q1 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $67 million versus the consensus estimate of $68.47 million.

For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Kimberly Clark (KMB) PT Raised to $150 at HSBC
• Capitol Federal Financial (CFFN) Misses Q2 EPS by 1c